News Feed Item

Resolution Supports Client's 510(k) Submission for Class II Medical Device

WOBURN, Mass., June 14, 2018 /PRNewswire/ -- Resolution Development Services Inc., a leading provider of product development services to the medical, life science and consumer markets, today announced the completion of the 510(k) pre-market submission for FDA review by a class II medical device customer for their next generation device.

Resolution played an instrumental role in the process to reach the submission stage.  Over a two year period, Resolution worked closely to not only develop the product but to also develop the comprehensive medical device documentation for the product needed as part of the regulatory submission.  This includes steps such as passing 60601 emissions and safety testing.

"We are pleased to see that this customer has taken the next step in their process", said Leo Carayannopoulos, CEO of Resolution Development Services. "It is these types of complex, medical device projects where Resolution is truly able to show our breadth of capabilities and deep regulatory knowledge."

Class II medical devices require stringent adherence to regulatory standards.  The product development process requires total coordination between development and documentation to reach the submission stage.  To learn more about 510(k) Clearances, visit the FDA website at

About Resolution Development Services:

With offices just outside of Boston, Resolution Development Services provides best in class hardware, software, mechanical, machine vision, and systems engineering outsourced services to clients in the United States, Canada, and Asia. Our regulatory compliant quality system makes Resolution the best choice for complex development programs.

To learn more about Resolution Development Services offerings, our charitable giving, and other partnerships, visit


Leo Carayannopoulos
[email protected]

Cision View original content with multimedia:

SOURCE Resolution Development Services, Inc

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.